Clinical Trials Logo

Mild Cognitive Impairment clinical trials

View clinical trials related to Mild Cognitive Impairment.

Filter by:

NCT ID: NCT01745198 Completed - Clinical trials for Mild Cognitive Impairment

Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements

Start date: December 2012
Phase: N/A
Study type: Observational

In a retrospective analysis of data from 1100 patients, disease-delaying effects of Cerefolin®/CerefolinNAC® were examined in terms of cognition. The purpose of the current study is to expand the retrospective study dataset by prospectively collecting additional biomarker and imaging data.

NCT ID: NCT01732653 Completed - Parkinson Clinical Trials

A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults

VTIME
Start date: November 2012
Phase: N/A
Study type: Interventional

The proposed randomized controlled trial will evaluate the effects of treadmill training augmented with virtual reality on fall risk. 300 older adults with a history of falls will be recruited to participate in this study. This will include older adults (n=100), patients with mild cognitive impairment (MCI) (n=100), and patients with Parkinson's disease (PD)(n=100). Subjects will be randomly assigned to the intervention group (treadmill training with virtual reality) or to the active-control group (treadmill training without virtual reality). Each person will participate in a training program set in an outpatient setting 3 times per week for 6 weeks. Assessments will take place before, after, and 1 month and 6 months after the completion of the training.

NCT ID: NCT01727622 Completed - Clinical trials for Mild Cognitive Impairment

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

Start date: August 2012
Phase:
Study type: Observational

The purpose of this study is to determine the value of Arterial Spin Labeling (ASL) MRI, a measure of blood flow to the brain, in Mild Cognitive Impairment (MCI) and compare it to existing measures. In particular, the investigators will compare ASL MRI to Positron Emission Tomography (PET/CT), which measures brain metabolism reflecting how well cells in a patient's brain are functioning. In addition, the investigators will assess the relationship of these measures to specific protein levels associated with Alzheimer's Disease in the patient's cerebrospinal fluid (the fluid that surrounds the brain and spinal cord) obtained by lumbar puncture. By comparing the information that is available from these procedures to the patient's performance on cognitive tests, the investigators hope to learn which procedures most accurately reflect and assist in determination of the potential causes of cognitive difficulties that arise with MCI, and thus, which are most useful in the clinical setting. In particular, PET scans have been found to be very useful in diagnosis of MCI and Alzheimer's Disease, but the investigators want to find out if they can get the same, or better, information from an ASL MRI scan, which is less expensive and easier to acquire.

NCT ID: NCT01725178 Active, not recruiting - Dementia Clinical Trials

Train the Brain - Cognitive and Physical Training for Slowing Dementia

TTB
Start date: March 2012
Phase: N/A
Study type: Interventional

Train The Brain is aimed at assessing the efficacy of cognitive and physical training in slowing progression to dementia in patients diagnosed with mild cognitive impairment (MCI).

NCT ID: NCT01724151 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Exercise Training in Patients With Mild Cognitive Impairment

Start date: April 2009
Phase: N/A
Study type: Observational

The proposes of this study are 1. To understand the physical activities of patients with cognitive impairment in Taiwan and construct the validity and reliability of the physical activity questionnaire and actigram in this population. 2. To understand the relation between brain structure (brain tractography and resting state functional MRI) and cognitive and physical functions of patients with cognitive impairment, the capability of activity and social engagement (including quality of life). 3. To understand the efficacy of exercise on the brain structure (brain tractography and resting state functional MRI), cognitive and physical functions, the capability of activity and social engagement (including quality of life) of the patients with cognitive impairment. The study aims to establish the data base of physical activity of patients with cognitive impairment in Taiwan. We will also analyze the efficacy of exercise with ICF model on physical function, physical activity and social engagements to provide an optimized design of exercise program for patients with cognitive impairment in the future.

NCT ID: NCT01723670 Withdrawn - Alzheimer's Disease Clinical Trials

Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment

CT05
Start date: December 2012
Phase: Phase 2
Study type: Interventional

To evaluate the effects of multiple dose regimens of CHF 5074 administered once per day up to 2 years on potential biomarkers of neurodegeneration in subjects with mild cognitive impairment.

NCT ID: NCT01708005 Enrolling by invitation - Clinical trials for Mild Cognitive Impairment

DIetary Supplements, Executive funcTions and Vitamin D (DIET-D)

DIET-D
Start date: November 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the effect after 12 weeks of the oral intake of Lecitone®Se + 200UI/day of D3 vitamin with the effect of a placebo on changes in cognitive performance in Trial Making Test score part B (this test evaluate executive functions of mental flexibility) in older adults with Mild Cognitive Impairment (MCI).

NCT ID: NCT01705210 Completed - Clinical trials for Diabetes Mellitus, Type 2

Functional MRI Biomarkers of Cognitive Decrements in Diabetes

Start date: May 2012
Phase: N/A
Study type: Observational

The exact neuronal mechanism underlying the cognitive decline associated with diabetes mellitus type 2 (DM2) still remains to be elucidated. Multi-parametric functional MRI can potentially provide functional, micro-structural, micro-vascular, and metabolic information on the affected brain at an earlier stage than does conventional structural MRI. The overall aim of the current proposal is to obtain a better understanding in the neuronal mechanisms that underlie cognitive decline in DM2 and the putative prediabetic condition the metabolic syndrome (MetS).

NCT ID: NCT01699503 Completed - Dementia Clinical Trials

Indiana University Dementia Screening Trial

IU-CHOICE
Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to conduct a randomized clinical trial assessing the harms and benefits of screening for dementia, compared to no screening for dementia, among 4,000 older adults, cared for in typical, primary care practices.

NCT ID: NCT01696019 Completed - Alzheimer Disease Clinical Trials

Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders

SCIBHI
Start date: July 2008
Phase: N/A
Study type: Interventional

A pilot randomized clinical trial was conducted in a random sample of 120 non-demented Chinese elders (ages 60-79) living in a defined community in Shanghai, China to compare the effects of interventions (fast walking, Tai Chi, group intellectual discussion) to no intervention with respect to change in cognition and whole brain volume determined by repeated neuropsychological batteries and MRI scans. Aims included determining the feasibility of recruiting and retaining a random sample of people age 60+ for such a trial as well as collection of preliminary data on the efficacy of the interventions. The long-term goal of this research program is to determine whether sustained physical and/or mental exercise interventions are efficacious in delaying the onset of dementia and to understand the role and mechanisms of brain growth in this process.